Category Archives: Investment

Healthcare IPOs still on a tear as pricings and registrations keep Wall Street, SEC on their toes.

Despite President Trump’s threatening trade Tweets to China and the resulting drag on stocks, only the health sector came out ahead on Monday (May 6, 2019), and the IPO action… Read more »

Healthcare stocks continue rise from the ashes as legislative uncertainties wane; sanity, fundamentals return.

Several Democratic presidential candidates have embraced “Medicare for all” as a rallying cry. Others are calling for a variety of healthcare reforms, such as lowering Medicare’s eligibility age from the… Read more »

Health-sector IPO action defies market jitters as Q1 earnings, the Federal Reserve and China trade talks take front stage.

Undaunted by the crushing weight of uncertainty affecting healthcare stock prices lately, the IPO action in New York continues to race ahead as though determined to prove Hong Kong’s budding… Read more »

Health stocks mount furious comeback after getting crushed by jitters about Medicare for All, the fate of the ACA and threats of new drug-pricing rules.

Here we go again. The S&P 500 healthcare sector fell 4.4% two weeks ago, its worst weekly decline since late December. The move ended with more than 93% of healthcare stocks trading… Read more »

Health sector stocks dead last after first-quarter wraps up; But some say outlook rosy due to strong fundamentals, unlikely changes to Obamacare.

“It’s all in how you look at it,” I was taught as a child by my immigrant grandparents. What does this have to do with evaluating the healthcare sector’s first-quarter… Read more »

Healthcare stocks display their resilience after bear market struck in December; well, most do.

The News: We’re hardly in a recession, and most forms of healthcare spending remain incredibly robust, regardless of what the overall economy does and what the White House says about… Read more »

Healthcare IPO dreamers not ready to throw in the towel despite recent market slump. Will 2019 stack up to 2018?

It’s now Daylight Saving Time and the question on the heretofore gloomy minds of a lot of us healthcare stock editorialists is: Will it be boom or kaboom for IPOs… Read more »

Voyager Therapeutics signs another neurodegenerative disease deal with AbbVie that screams “Buy this small cap now.”

The News: Voyager Therapeutics Inc. (Cambridge MA) struck a deal with AbbVie Inc. (North Chicago) to develop and commercialize vectorized antibodies directed at pathological species of alpha-synuclein for the potential treatment of Parkinson’s… Read more »